MX2018015240A - Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica. - Google Patents
Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.Info
- Publication number
- MX2018015240A MX2018015240A MX2018015240A MX2018015240A MX2018015240A MX 2018015240 A MX2018015240 A MX 2018015240A MX 2018015240 A MX2018015240 A MX 2018015240A MX 2018015240 A MX2018015240 A MX 2018015240A MX 2018015240 A MX2018015240 A MX 2018015240A
- Authority
- MX
- Mexico
- Prior art keywords
- timolol
- rosacea
- compositions
- treatment
- topical administration
- Prior art date
Links
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 title abstract 3
- 229960004605 timolol Drugs 0.000 title abstract 3
- 241001303601 Rosacea Species 0.000 title abstract 2
- 201000004700 rosacea Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 238000011200 topical administration Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere al uso de timolol en el tratamiento de rosácea y a composiciones farmacéuticas que comprenden timolol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382278 | 2016-06-16 | ||
| PCT/EP2017/064704 WO2017216307A1 (en) | 2016-06-16 | 2017-06-15 | Compositions comprising timolol and their use in the treatment of rosacea by topical administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018015240A true MX2018015240A (es) | 2019-04-15 |
Family
ID=56203291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018015240A MX2018015240A (es) | 2016-06-16 | 2017-06-15 | Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210220368A1 (es) |
| EP (1) | EP3471731A1 (es) |
| JP (1) | JP2019518039A (es) |
| KR (1) | KR20190017801A (es) |
| CN (1) | CN109475561A (es) |
| AR (1) | AR108792A1 (es) |
| AU (1) | AU2017285256A1 (es) |
| BR (1) | BR112018076014A2 (es) |
| CA (1) | CA3026974A1 (es) |
| EA (1) | EA201990041A1 (es) |
| MA (1) | MA45378A (es) |
| MX (1) | MX2018015240A (es) |
| TW (1) | TW201803568A (es) |
| WO (1) | WO2017216307A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118453616A (zh) * | 2022-08-01 | 2024-08-09 | 北京梅尔森医药技术开发有限公司 | 一种治疗敏感肌肤的外用制剂及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866567A1 (fr) * | 2004-02-20 | 2005-08-26 | Galderma Res & Dev | Utilisation d'un antagoniste du recepteur beta-adrenergique, at1, 5-ht2, 5-ht5 et/ou de la galanine, pour le traitement de la rosacee |
| US20090214643A1 (en) * | 2005-07-19 | 2009-08-27 | Franklin Amie E | Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| FR2961695B1 (fr) | 2010-06-29 | 2012-07-06 | Galderma Res & Dev | Utilisation de composes dans le traitement ou la prevention de troubles cutanes |
-
2017
- 2017-06-15 WO PCT/EP2017/064704 patent/WO2017216307A1/en not_active Ceased
- 2017-06-15 EP EP17729880.9A patent/EP3471731A1/en not_active Withdrawn
- 2017-06-15 US US16/309,808 patent/US20210220368A1/en not_active Abandoned
- 2017-06-15 JP JP2018565309A patent/JP2019518039A/ja active Pending
- 2017-06-15 EA EA201990041A patent/EA201990041A1/ru unknown
- 2017-06-15 AU AU2017285256A patent/AU2017285256A1/en not_active Abandoned
- 2017-06-15 MA MA045378A patent/MA45378A/fr unknown
- 2017-06-15 CN CN201780042807.3A patent/CN109475561A/zh active Pending
- 2017-06-15 MX MX2018015240A patent/MX2018015240A/es unknown
- 2017-06-15 KR KR1020187036463A patent/KR20190017801A/ko not_active Withdrawn
- 2017-06-15 BR BR112018076014-5A patent/BR112018076014A2/pt not_active Application Discontinuation
- 2017-06-15 AR ARP170101655A patent/AR108792A1/es unknown
- 2017-06-15 CA CA3026974A patent/CA3026974A1/en not_active Abandoned
- 2017-06-16 TW TW106120188A patent/TW201803568A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR108792A1 (es) | 2018-09-26 |
| CA3026974A1 (en) | 2017-12-21 |
| EP3471731A1 (en) | 2019-04-24 |
| CN109475561A (zh) | 2019-03-15 |
| MA45378A (fr) | 2019-04-24 |
| EA201990041A1 (ru) | 2019-05-31 |
| TW201803568A (zh) | 2018-02-01 |
| US20210220368A1 (en) | 2021-07-22 |
| JP2019518039A (ja) | 2019-06-27 |
| KR20190017801A (ko) | 2019-02-20 |
| AU2017285256A1 (en) | 2019-01-24 |
| WO2017216307A1 (en) | 2017-12-21 |
| BR112018076014A2 (pt) | 2019-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501139A1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
| MX378273B (es) | Compuestos activos hacia bromodominios. | |
| PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
| MX2017002816A (es) | Derivados de pirazolopiridina y su uso en terapia. | |
| EA201591925A1 (ru) | Терапевтические композиции и их применение | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| EA202090270A1 (ru) | Новые замещенные производные ксантина | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12015502564A1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
| PH12018500450A1 (en) | Immunity enhancing agent for cancer by allergin-1 antagonist | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| IN2013MU03118A (es) | ||
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| MX2018015240A (es) | Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica. | |
| EP3881845A3 (en) | Combination of trazodone and gabapentin for the treatment of pain | |
| HK1263089A1 (zh) | 包含噻吗洛尔的组合物及其在通过局部给药治疗红斑痤疮中的应用 | |
| MX2016012553A (es) | Composiciones farmaceuticas de mazindol con metformina para perdida de peso. | |
| WO2016164719A3 (en) | Methods used to treat cancer |